Dendrimers News

RSS

Starpharrma Report Advancement in its Dendrimer-based Drug-Delivery Program

A Starpharma dendrimer combined with a widely-used cancer drug (doxorubicin) has achieved a significant extension of the drug's plasma half-life and a marked reduction in drug toxicity compared to administration of the drug alone.

17 Dec 2008

Starpharma Announces Key VivaGel Patent Approved in Japan

Starpharma Holdings Limited, a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications, today announced that one of its key patents relating to the use of dendr...

From Starpharma Holdings Ltd 30 Oct 2008

Global Nanomaterials Market to Reach $10 Billion by 2012

Nanomaterials of all types are poised to register robust growth driven by growing interest from healthcare and electronics sectors. Oxides and metals are expected to capture a major share of global NanoMaterial revenues ...

From Global Industry Analysts 29 Oct 2008

Hyperbranched Polymers Could Soon Unleash Potential Of Nanotechnology

Materials science and the pharmaceutical industry could soon be revolutionized by emerging nanotechnologies based on designer molecules with long complex tree-and branch structures. Such molecules offer almost limitless ...

24 Oct 2008

Exciting Advances in the Ability to Work at the Atomic Level to be Unveiled at nanotxUSA'08

Among the more dramatic tools to be demonstrated during International Nanotechnology Week at the Hyatt Regency Dallas convention hotel October 2-3 is by InsituTec Inc, a Nano-Tool company commercializing an innovative pl...

9 Sep 2008

Start-Up Companies Receives Financial Boost to Advance Their Nanotechnology Research

Two start-up companies spun out of UniQuest, The University of Queensland's main commercialisation company, have received a financial boost to advance their research priorities. Uniseed Management Pty Ltd, which ...

18 Aug 2008

Nanoparticle Characterization Crucial for Developers of Drug Delivery Systems

Nanoparticle characterization using the Zetasizer Nano from Malvern Instruments is providing essential information for researchers working on drug delivery systems at the UK’s newest School of Pharmacy and Pharmaceutical Sciences.

26 Jun 2008

DNA Transfection Reagent Kit Launched

Starpharma Holdings Ltd today announced the first commercial product launch based on its Priostar® dendrimer technology. The product, a research reagent kit called NanoJuiceTM Transfection Kit for transporting DNA...

22 Apr 2008

Cancer Tumors Targeted by Nanoparticles

As a wide variety of nanoparticles continue to demonstrate their ability to improve the delivery of imaging agents and drugs to tumors, nanoparticle researchers have turned their attention to the challenge of systematica...

28 Mar 2008

Targeted Dendrimer Advances in Preclinical Studies

Although a variety of nanoparticles continue to show promise for improving cancer imaging and therapy, regulators and drug developers are concerned that these delivery systems may prove difficult to manufacture on a cons...

4 Mar 2008